Get More Information on Home Infusion Therapy Market - Request Sample Report
The Home Infusion Therapy Market Size was valued at USD 35.98 Billion in 2023, and is expected to reach USD 71.82 Billion by 2032, and grow at a CAGR of 8.36%.
The Home Infusion Therapy market is witnessing substantial growth, primarily fueled by the rising prevalence of chronic diseases and an increasing demand for patient-centric healthcare solutions. The Centers for Disease Control and Prevention (CDC) reports that nearly 60% of adults in the United States live with at least one chronic disease, including heart disease, diabetes, and respiratory conditions. This statistic highlights the urgent need for effective home healthcare solutions that empower patients to manage their conditions independently, thereby reducing the frequency of hospital visits and minimizing the associated healthcare costs. Chronic diseases often necessitate long-term treatments that can be cumbersome and challenging for patients to receive in traditional healthcare settings. Home infusion therapy offers a practical alternative, allowing patients to receive necessary medications in the comfort of their homes. This mode of therapy not only enhances patient convenience but also improves compliance with treatment regimens. As healthcare systems continue to evolve, the focus is increasingly shifting toward providing care in a more patient-centered manner, aligning with the growing preference for home-based solutions.
Moreover, advancements in technology have significantly contributed to the growth of the Home Infusion Therapy market. Innovations in infusion devices and drug delivery systems, such as smart pumps equipped with monitoring capabilities, have enhanced patient safety and treatment efficacy. These technological improvements have made it easier for healthcare professionals to oversee home infusion therapy remotely, ensuring timely interventions when necessary. For instance, the integration of telehealth services has enabled healthcare providers to conduct virtual consultations, monitor patient conditions, and adjust treatment plans in real-time, further promoting the adoption of home infusion therapy. Government policies and reimbursement structures are also pivotal in shaping the market landscape. The Centers for Medicare & Medicaid Services (CMS) have implemented various initiatives aimed at expanding coverage for home health services, which directly benefits home infusion therapy. Increased reimbursement rates and simplified regulatory requirements have made it more accessible for patients to receive infusion therapies at home. As a result, healthcare providers are more likely to offer these services, knowing that they are supported by favorable reimbursement frameworks.
Key Drivers:
Increasing Incidence of Chronic Conditions Such as Diabetes, Cancer, And Cardiovascular Diseases Drives the Demand for Home Infusion Therapy
Innovations in Infusion Devices and Drug Delivery Systems Enhance Patient Safety and Comfort, Contributing to The Growth of Home Infusion Therapy Services
Restraints:
Strict Regulatory Requirements and Compliance Issues Can Hinder the Adoption and Expansion of Home Infusion Therapy Services, Particularly in Varying Markets.
Inadequate Reimbursement for Home Infusion Therapy from Insurance Providers May Restrict Patient Access and Limit Market Growth.
Opportunity:
An Aging Population Increases the Need for Home Healthcare Services, Including Infusion Therapy, Presenting Significant Market Growth Potential.
The Integration of Telehealth into Home Healthcare Can Facilitate Better Monitoring and Management of Infusion Therapies, Improving Patient Outcomes and Driving Demand.
By Product
In the Home Infusion Therapy Market, Infusion Pumps held a substantial market share of 45% in 2023. Infusion pumps are critical in delivering precise amounts of medication and nutrients to patients, ensuring accurate dosing and reducing the risk of errors. The demand for advanced infusion pumps has surged due to their ability to improve patient outcomes and enhance safety in home healthcare settings. A report by the FDA indicated that the use of infusion pumps has been associated with a 50% reduction in medication administration errors, driving their adoption among healthcare providers and patients alike. Furthermore, advancements in technology, such as the integration of smart infusion systems and remote monitoring capabilities, have positioned infusion pumps as the preferred choice for home infusion therapy, contributing to their dominance in the market.
By Application
Anti-infective therapy accounted for 35% of the market share in 2023. The high prevalence of infectious diseases, coupled with the rising incidence of antibiotic-resistant infections, has driven the demand for effective anti-infective treatments delivered in a home setting. According to the World Health Organization (WHO), antimicrobial resistance (AMR) is a growing global health threat, causing an estimated 700,000 deaths annually, with projections suggesting that this number could rise to 10 million by 2050 if not addressed. This alarming statistic highlights the urgent need for effective anti-infective therapies, further stimulating market growth. Home infusion allows for continuous and consistent delivery of these therapies, reducing hospital stays and improving patient quality of life, which is crucial in managing infections.
In 2023, North America was the dominant region in the home infusion therapy market, holding a market share of approximately 40%. This dominance can be attributed to several factors, including advanced healthcare infrastructure, a high prevalence of chronic diseases, and a rapidly growing elderly population in the region. According to the U.S. Census Bureau, the population aged 65 and older is projected to reach about 95 million by 2060, nearly doubling from 52 million in 2021. This demographic shift is expected to significantly increase the demand for home healthcare services, including home infusion therapy. Recent statistics from the National Center for Health Statistics indicate that approximately 30% of older adults in the U.S. manage two or more chronic conditions, further driving the need for effective home healthcare solutions. Additionally, favorable reimbursement policies and government initiatives, such as those from the Centers for Medicare & Medicaid Services (CMS), have expanded coverage for home health services, allowing more patients to access home infusion therapy. In 2023, CMS reported that home health expenditures reached USD 100 billion, reflecting a 15% increase compared to the previous year. This trend reinforces North America’s position as a leader in the home infusion therapy market, with significant growth potential in the coming years.
Need any customization research on Home Infusion Therapy Market - Enquiry Now
The players operating in the home infusion therapy market are the following:
CVS/Coram: Coram Infusion Services
Option Care Health: Option Care Infusion Products
BriovaRx/Diplomat (UnitedHealth Optum): BriovaRx Infusion Therapy
PharMerica: PharMerica Infusion Services
Fresenius Kabi: Kabi IV Systems, Kabi Pharmaceuticals
ICU Medical, Inc.: ICU Medical Infusion Systems, CLAVE Connector
B. Braun Melsungen AG: Infusomat Space, Perfusor Space
Baxter: Baxter Infusion Pumps, Sigma Spectrum Infusion System
BD (Becton, Dickinson, and Company): BD Alaris System, BD Nexiva Catheter
Caesarea Medical Electronics: CME Infusion Systems
Smith’s Medical: CADD Infusion Systems, Medfusion Syringe Pumps
Terumo Corporation: Terumo Infusion Systems, Terumo Medisafe Infusion System
JMS Co. Ltd.: JMS Infusion Devices
Medtronic: MiniMed Infusion Systems
Halyard Health (now part of Owens & Minor): Halyard Infusion Solutions
Zyno Medical: Zyno Infusion Pumps
Alaris Medical Systems (part of BD): Alaris System
Calea: Calea Infusion Products
Nipro Medical Corporation: Nipro Infusion Devices
HMC (Health Management Corporation): HMC Infusion Services
Pall Corporation: Pall Infusion Filters
In June 2023, an American healthcare company, Baxter International announced the Progressa+ Next Gen ICU bed that is designed to meet the emergency needs of patients at their homes. This technology facilitates the task performance of nurses at the same time promotes therapy at home.
In May 2023, Fresenius Kabi, a global healthcare firm, established an agreement with Premier, Inc., an American healthcare company that resulted in the capability to offer pricing and term stipulations for the Ivenix Infusion System.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 35.98 Billion |
| Market Size by 2032 | US$ 71.82 Billion |
| CAGR | CAGR of 8.36% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), •By Application (Anti-Infective, Endocrinology, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Others) •By Route of Administration (Intramuscular, Subcutaneously, Epidural) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical, Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, and Terumo Corporation, as well as JMS Co. Ltd. |
| Key Drivers | •Increasing Incidence of Chronic Conditions Such as Diabetes, Cancer, And Cardiovascular Diseases Drives the Demand for Home Infusion Therapy •Innovations in Infusion Devices and Drug Delivery Systems Enhance Patient Safety and Comfort, Contributing to The Growth of Home Infusion Therapy Services |
| RESTRAINTS | •Strict Regulatory Requirements and Compliance Issues Can Hinder the Adoption and Expansion of Home Infusion Therapy Services, Particularly in Varying Markets. •Inadequate Reimbursement for Home Infusion Therapy from Insurance Providers May Restrict Patient Access and Limit Market Growth. |
Ans: The rising healthcare expenses and the government support supportive actions for the home infusion therapy.
Ans: The Home Infusion Therapy Market Size was valued at USD 35.98 Billion in 2023 and is expected to reach USD 71.82 Billion by 2032 and grow at a CAGR of 8.36% over the forecast period 2024-2032
Ans: North America region will dominate the market.
Ans: Patients who require home infusion therapy treatments may have less access to care as a result of a downturn in the industry.
Ans: The major key players are CVS/Coram, BD, Option Care Health, Baxter, Smith’s Medical, B Braun Melsungen Ag, JMS Corp Ltd, Terumo Corp. and others.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Drugs Volume: Device usage volume
5.4 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Home Infusion Therapy Market Segmentation, by Product
7.1 Chapter Overview
7.2 Infusion Pumps
7.2.1 Infusion Pumps Market Trends Analysis (2020-2032)
7.2.2 Infusion Pumps Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Intravenous Sets
7.3.1 Intravenous Sets Market Trends Analysis (2020-2032)
7.3.2 Intravenous Sets Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 IV Cannulas
7.4.1 IV Cannulas Market Trends Analysis (2020-2032)
7.4.2 IV Cannulas Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Needleless Connectors
7.5.1 Needleless Connectors Market Trends Analysis (2020-2032)
7.5.2 Needleless Connectors Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Home Infusion Therapy Market Segmentation, by Application
8.1 Chapter Overview
8.2 Anti-Infective
8.2.1 Anti-Infective Market Trends Analysis (2020-2032)
8.2.2 Anti-Infective Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Endocrinology
8.3.1 Endocrinology Market Trends Analysis (2020-2032)
8.3.2 Endocrinology Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Chemotherapy
8.4.1 Chemotherapy Market Trends Analysis (2020-2032)
8.4.2 Chemotherapy Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Enteral Nutrition
8.5.1 Enteral Nutrition Market Trends Analysis (2020-2032)
8.5.2 Enteral Nutrition Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Parenteral Nutrition
8.6.1 Parenteral Nutrition Market Trends Analysis (2020-2032)
8.6.2 Parenteral Nutrition Market Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Others
8.7.1 Others Market Trends Analysis (2020-2032)
8.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Home Infusion Therapy Market Segmentation, by Route of Administration
9.1 Chapter Overview
9.2 Intramuscular
9.2.1 Intramuscular Market Trends Analysis (2020-2032)
9.2.2 Intramuscular Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Subcutaneously
9.3.1 Subcutaneously Market Trends Analysis (2020-2032)
9.3.2 Subcutaneously Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Epidural
9.4.1 Epidural Market Trends Analysis (2020-2032)
9.4.2 Epidural Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Home Infusion Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.4 North America Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.5 North America Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.6.2 USA Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.6.3 USA Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.7.2 Canada Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.7.3 Canada Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.2.8.3 Mexico Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Home Infusion Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.6.3 Poland Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.7.3 Romania Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Home Infusion Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.5 Western Europe Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.6.3 Germany Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.7.2 France Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.7.3 France Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.8.3 UK Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.9.3 Italy Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.10.3 Spain Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.13.3 Austria Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Home Infusion Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.5 Asia Pacific Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.6.2 China Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.6.3 China Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.7.2 India Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.7.3 India Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.8.2 Japan Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.8.3 Japan Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.9.3 South Korea Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.10.3 Vietnam Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.11.3 Singapore Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.12.2 Australia Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.12.3 Australia Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Home Infusion Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.5 Middle East Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.6.3 UAE Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Home Infusion Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.4 Africa Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.5 Africa Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Home Infusion Therapy Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.4 Latin America Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.5 Latin America Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.6.3 Brazil Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.7.3 Argentina Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.8.3 Colombia Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Home Infusion Therapy Market Estimates and Forecasts, by Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Home Infusion Therapy Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Home Infusion Therapy Market Estimates and Forecasts, by Route of Administration (2020-2032) (USD Billion)
11. Company Profiles
11.1 CVS/Coram
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product / Services Offered
11.1.4 SWOT Analysis
11.2 Option Care Health
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product / Services Offered
11.2.4 SWOT Analysis
11.3 BriovaRx/Diplomat (UnitedHealth Optum)
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product / Services Offered
11.3.4 SWOT Analysis
11.4 PharMerica
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product / Services Offered
11.4.4 SWOT Analysis
11.5 Fresenius Kabi
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product / Services Offered
11.5.4 SWOT Analysis
11.6 ICU Medical, Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product / Services Offered
11.6.4 SWOT Analysis
11.7 B. Braun Melsungen AG
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product / Services Offered
11.7.4 SWOT Analysis
11.8 Baxter
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product / Services Offered
11.8.4 SWOT Analysis
11.9 BD
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product / Services Offered
11.9.4 SWOT Analysis
11.10 Caesarea Medical Electronics
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product / Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product
Infusion Pumps
Intravenous Sets
IV Cannulas
Needleless Connectors
By Application
Anti-Infective
Endocrinology
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Others
By Route of Administration
Intramuscular
Subcutaneously
Epidural
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Single-use Bioprocessing Market size was USD 26.8 billion in 2023 and is expected to reach USD 100.9 billion by 2032 at a CAGR of 15.9%.
The Consumer Genomics Market size was estimated at USD 2.18 billion in 2023 and is expected to reach USD 14.08 billion by 2032 at a CAGR of 23.04% during the forecast period of 2024-2032.
The Exosomes Market size was estimated at USD 113.3 million in 2022 and is expected to reach USD 1076.35 million by 2030 with a growing CAGR of 32.5% during the forecast period of 2023-2030.
The global palliative care market size was USD 10.7 billion in 2023 and is anticipated to grow at a CAGR of 9.06% to reach USD 23.34 Billion by 2032.
The Tissue Engineering Market was valued at USD 16.8 Billion in 2023 and will reach USD 56.2 Billion by 2032, with a CAGR of 14.3% from 2024-2032.
The Medical Display Market Size was valued at USD 2.2 billion in 2023 and is expected to reach USD 3.27 billion by 2031, and grow at a CAGR of 5.1% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
